Recurrent Primary Angiosarcoma of the Breast: Challenges and Pitfalls in a Case Report.

Ann Ital ChirOct 14, 2026

Chiara Valeria Pirrottina, Angela Bucaro, Alejandro Martin Sanchez et al.

✦ AI-curated · Sources linked

Case in brief

A patient presented with a breast lesion and skin involvement; histopathology and immunohistochemistry confirmed low- to intermediate-grade primary breast angiosarcoma. After skin-reducing mastectomy, the disease recurred early and progressed systemically despite radiotherapy and multiple lines of chemotherapy. The patient’s overall survival was 102 months from diagnosis, despite progressive disease.

What made this case unusual

Survival of 102 months was unusually prolonged for this aggressive, recurrent disease; the report does not establish which, if any, treatments contributed to that outcome.

Diagnostic / clinical pearl

Histopathological and immunohistochemical assessment is central to confirming primary breast angiosarcoma, and recurrence risk supports prolonged surveillance.

Source

Published in Ann Ital Chir. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.